NCT06830265View on ClinicalTrials.gov

Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis

NANot yet recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 10, 2026

Conditions

Prostate Cancer Screening

Interventions

DEVICE

Novel needle biopsy catheter (test)

Tissue is collected from the prostate by introducing a needle into the prostate and cutting out a sample

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

collaborator

NYU Langone Health

OTHER

lead

Uro-1 Medical

INDUSTRY

NCT06830265 - Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis | Biotech Hunter | Biotech Hunter